Nana Kragh

703 total citations
27 papers, 530 citations indexed

About

Nana Kragh is a scholar working on Endocrinology, Diabetes and Metabolism, Dermatology and Immunology and Allergy. According to data from OpenAlex, Nana Kragh has authored 27 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Dermatology and 6 papers in Immunology and Allergy. Recurrent topics in Nana Kragh's work include Diabetes Treatment and Management (8 papers), Dermatology and Skin Diseases (8 papers) and Diabetes Management and Research (8 papers). Nana Kragh is often cited by papers focused on Diabetes Treatment and Management (8 papers), Dermatology and Skin Diseases (8 papers) and Diabetes Management and Research (8 papers). Nana Kragh collaborates with scholars based in Denmark, United Kingdom and United States. Nana Kragh's co-authors include Mette Hammer, Julie Hahn-Pedersen, Weiwei Xu, Amy Barrett, Ari Gnanasakthy, Stephen Gough, Barnaby Hunt, William J. Valentine, Jonathan I. Silverberg and James Piercy and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of the American Academy of Dermatology and Quality of Life Research.

In The Last Decade

Nana Kragh

26 papers receiving 519 citations

Peers

Nana Kragh
S. D. Hsieh Japan
Ragna Lind Norway
Mohamed-Syarif Mohamed-Yassin Malaysia
Jeffrey Wald United States
Pakaphan Kiatchoosakun Thailand
E Eyles New Zealand
Rafael Violante Mexico
Zhijun Lun China
Sophia C. Jansen Netherlands
Rosirene Paczkowski United States
S. D. Hsieh Japan
Nana Kragh
Citations per year, relative to Nana Kragh Nana Kragh (= 1×) peers S. D. Hsieh

Countries citing papers authored by Nana Kragh

Since Specialization
Citations

This map shows the geographic impact of Nana Kragh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nana Kragh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nana Kragh more than expected).

Fields of papers citing papers by Nana Kragh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nana Kragh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nana Kragh. The network helps show where Nana Kragh may publish in the future.

Co-authorship network of co-authors of Nana Kragh

This figure shows the co-authorship network connecting the top 25 collaborators of Nana Kragh. A scholar is included among the top collaborators of Nana Kragh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nana Kragh. Nana Kragh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Klamroth, Robert, Patricia Guyot, A. Arnaud, et al.. (2023). PB0201 Efanesoctocog Alfa Versus Extended Half-Life Factor VIII Therapies for Prophylaxis in Adolescents and Adults with Severe Hemophilia A: A Matching-Adjusted Indirect Comparison and Meta-Analysis. Research and Practice in Thrombosis and Haemostasis. 7. 101290–101290. 1 indexed citations
3.
Román, María, Nana Kragh, Patricia Guyot, et al.. (2023). PB0195 Efanesoctocog Alfa Versus Emicizumab in the Prophylactic Treatment of Adolescents and Adults with Severe Hemophilia A without Inhibitors: A Matching-Adjusted Indirect Comparison. Research and Practice in Thrombosis and Haemostasis. 7. 101295–101295. 1 indexed citations
4.
5.
Hahn-Pedersen, Julie, et al.. (2020). Impact of Atopic Dermatitis and Chronic Hand Eczema on Quality of Life Compared With Other Chronic Diseases. Dermatitis. 31(3). 178–184. 40 indexed citations
6.
Silverberg, Jonathan I., Emma Guttman‐Yassky, Melinda Gooderham, et al.. (2020). Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis. Annals of Allergy Asthma & Immunology. 126(5). 576–583.e4. 19 indexed citations
7.
8.
Grant, Laura, Jonathan I. Silverberg, William Abramovits, et al.. (2019). Conceptual Model to Illustrate the Symptom Experience and Humanistic Burden Associated With Atopic Dermatitis in Adults and Adolescents. Dermatitis. 30(4). 247–254. 27 indexed citations
9.
Barrett, Amy, et al.. (2019). Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Hand Eczema in Adults. Patient. 12(5). 445–459. 59 indexed citations
10.
Barrett, Amy, Julie Hahn-Pedersen, Nana Kragh, Emily Evans, & Ari Gnanasakthy. (2019). PSY52 PATIENT-REPORTED OUTCOME MEASURES IN ATOPIC DERMATITIS AND CHRONIC HAND ECZEMA IN ADULTS. Value in Health. 22. S911–S911. 1 indexed citations
11.
Mezquita‐Raya, Pedro, et al.. (2017). Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain. Diabetes Therapy. 8(2). 401–415. 14 indexed citations
12.
Hunt, Barnaby, et al.. (2017). Evaluation of the long‐term cost‐effectiveness of liraglutide vs lixisenatide for treatment of type 2 diabetes mellitus in the UK setting. Diabetes Obesity and Metabolism. 19(6). 842–849. 19 indexed citations
13.
14.
Kragh, Nana, et al.. (2016). Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review. Diabetes Therapy. 7(3). 411–438. 69 indexed citations
15.
Kragh, Nana, et al.. (2015). A Novel Tool to Measure The Subjective Burden of Acute Post-Prandial Hyperglycaemia (Pphg). Value in Health. 18(7). A615–A615. 1 indexed citations
16.
Heller, Simon, et al.. (2015). Investigating the Evidence of the Real-Life Impact of Acute Hyperglycaemia. Diabetes Therapy. 6(3). 389–393. 5 indexed citations
17.
Doward, Lynda, Lise Højbjerre, Carla DeMuro, et al.. (2015). Influence of Patient-Reported outcomes on Regulatory, Hta and Market access decisions: obesity and diabetes case Examples. Value in Health. 18(3). A65–A65.
18.
Brod, Meryl, et al.. (2010). Development and validation of the Treatment Related Impact Measure of Weight (TRIM-Weight). Health and Quality of Life Outcomes. 8(1). 19–19. 12 indexed citations
19.
Gough, Stephen, et al.. (2009). Impact of obesity and type 2 diabetes on health-related quality of life in the general population in England. Diabetes Metabolic Syndrome and Obesity. 2. 179–179. 21 indexed citations
20.
Hammer, Mette, et al.. (2009). The association of body mass index and health-related quality of life in the general population: data from the 2003 Health Survey of England. Quality of Life Research. 18(10). 1293–9. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. D. Hsieh Breakdown of academic impact, for papers by Ragna Lind Breakdown of academic impact, for papers by Mohamed-Syarif Mohamed-Yassin Breakdown of academic impact, for papers by Jeffrey Wald Breakdown of academic impact, for papers by Pakaphan Kiatchoosakun Breakdown of academic impact, for papers by E Eyles Breakdown of academic impact, for papers by Rafael Violante Breakdown of academic impact, for papers by Zhijun Lun Breakdown of academic impact, for papers by Sophia C. Jansen Breakdown of academic impact, for papers by Rosirene Paczkowski
Rankless by CCL
2026